Correlation of MTAP Protein Expression with MTAP and CDKN2A Copy Number in Malignant Pleural Mesothelioma

January 15, 2021 | Comments Off on Correlation of MTAP Protein Expression with MTAP and CDKN2A Copy Number in Malignant Pleural Mesothelioma

Histopathology 2021 January 2 [Link] David B Chapel, Adrian M Dubuc, Jason L Hornick, Lynette M Sholl Abstract Aims: MTAP immunohistochemistry is a specific marker of CDKN2A deletion in malignant…

Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)

January 14, 2021 | Comments Off on Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)

Cancers 2020 December 22 [Link] Moshe Lapidot, Abigail E Case, Dalia Larios, Helen I Gandler, Chengcheng Meng, Isidora Tošić, Ellen L Weisberg, Michael J Poitras, Prafulla C Gokhale, Cloud P…

Clinical features and surgical outcomes of major urological interventions during cytoreductive surgery and hyperthermic intraperitoneal chemotheraphy

January 13, 2021 | Comments Off on Clinical features and surgical outcomes of major urological interventions during cytoreductive surgery and hyperthermic intraperitoneal chemotheraphy

Therapeutic Advances in Urology 2020 December 10 [Link] Özgül Düzgün, Murat Kalın, Resul Sobay, Ömer Faruk Özkan Abstract Background: Urinary system resections and reconstructions are needed in peritoneal carcinomatosis due…

Malignant pleural neoplasm with both differentiation of epithelioid mesothelioma and squamous-cell carcinoma, a rare phenomena

January 12, 2021 | Comments Off on Malignant pleural neoplasm with both differentiation of epithelioid mesothelioma and squamous-cell carcinoma, a rare phenomena

Diagnostic Cytopathology 2020 December 21 [Link] Ashley Re, David Shersher, Ashleigh Allen, Roland Schwarting, Shuyue Ren Abstract Malignant mesothelioma, a neoplasm arising within the serosal surfaces, has been linked closely…

Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker

January 11, 2021 | Comments Off on Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker

Clinical Chemistry 2020 December 18 [Link] Kai Bartkowiak, Swaantje Casjens, Antje Andreas, Lucija Ačkar, Simon A Joosse, Irina Raiko, Thomas Brüning, Maria Geffken, Sven Peine, Georg Johnen, Daniel Gilbert Weber,…

Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders

January 8, 2021 | Comments Off on Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders

Safety and Health at Work 2020 December [Link] Eun-Kee Park, Anthony R Johnson, Donald Wilson, Paul S Thomas, Deborah H Yates Abstract Background: Asbestos exposure is associated with the development…

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

January 7, 2021 | Comments Off on High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

European Journal of Cancer 2020 December 13 [Link] Luca Cantini, Federica Pecci, Daan P Hurkmans, Robert A Belderbos, Andrea Lanese, Cecilia Copparoni, Sophie Aerts, Robin Cornelissen, Daphne W Dumoulin, Ilaria…

The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis

January 6, 2021 | Comments Off on The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis

Frontiers in Oncology 2020 November 13 [Link] Olivia Lauk, Karina Bruestle, Thomas Neuer, Bianca Battilana, Thi Dan Linh Nguyen, Thomas Frauenfelder, Rolf Stahel, Walter Weder, Alessandra Curioni-Fontecedro, Isabelle Opitz Abstract…

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

January 5, 2021 | Comments Off on Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

Investigational New Drugs 2020 December 9 [Link] Irene Dell’Anno, Sarah A Martin, Marcella Barbarino, Alessandra Melani, Roberto Silvestri, Maria Bottaro, Elisa Paolicchi, Alda Corrado, Monica Cipollini, Ombretta Melaiu, Antonio Giordano,…

Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients

January 4, 2021 | Comments Off on Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients

Annals of Surgery 2020 December 3 [Link] Moshe Lapidot, Ritu R Gill, Emanuele Mazzola, Samuel Freyaldenhoven, Scott J Swanson, Michael T Jaklitsch, David J Sugarbaker, Raphael Bueno Abstract Objective: We…

Categories